Data / Form D filings / ONCOSEC MEDICAL Inc
ONCOSEC MEDICAL Inc: Form D filings
ONCOSEC MEDICAL Inc, a biotechnology company in Ewing, NJ, filed 5 Form D notices with the SEC between 2011 and 2023. The latest, on May 26, 2023, reports an offering of no set size with nothing sold yet to 7 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 820 BEAR TAVERN ROAD, Ewing, NJ, 08628
- Phone
- (855) 662-6732
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Nevada
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1444307
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 26, 2023 | New notice | Indefinite | $0 | 7 | May 16, 2023 | sec.gov | |
| Apr 24, 2023 | New notice | Indefinite | $0 | 7 | Apr 11, 2023 | sec.gov | |
| Nov 28, 2017 | New notice | $5,685,507 | $5,685,507 | 9 | Nov 13, 2017 | sec.gov | |
| Nov 2, 2017 | New notice | $4,941,500 | $4,941,500 | 9 | Oct 25, 2017 | sec.gov | |
| Jul 1, 2011 | New notice | $3,000,000 | $3,000,000 | 2 | Jun 24, 2011 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Chao H. Zhou | Director | |
| Linda H. Shi | Director | |
| Robert H. Arch | Executive Officer, Director | |
| George H. Chi | Executive Officer | |
| Stephany R Foster | Director | |
| Joon R Kim | Director | |
| Herbert Kim Lyerly | Director | |
| Kevin R Smith | Director |
Other biotechnology companies in New Jersey that filed recently
- Ensho Therapeutics, Inc. $7.3 million · Oct 15, 2026
- Xenon Ophthalmics Inc $3.3 million · Oct 6, 2026
- LISATA THERAPEUTICS, INC. $351.9 million · Oct 2, 2026
- Bullseye Biodevices, Inc. $1.3 million · Aug 10, 2026
- Hepion Pharmaceuticals, Inc. $3.1 million · Aug 5, 2026
Every Form D from the week of May 22, 2023 · All recent filings in New Jersey · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what ONCOSEC MEDICAL Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.